Potential diagnostic value of 131I-MIBG myocardial scintigraphy in discrimination between Alzheimer disease and dementia with Lewy bodies
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Neurology and Neurosurgery"
DOI: 10.1016/j.clineuro.2017.10.024
Abstract: OBJECTIVES Clinical difficulty to discriminate between the Alzheimer disease (AD) and dementia with Lewy bodies (DLB) has led researchers to focus on highly sensitive functional imaging modalities. The aim of the present study was to… read more here.
Keywords: myocardial scintigraphy; 131i mibg; alzheimer disease; value ... See more keywords
101. Tandem high-dose 131I-mIBG therapy in paediatrics: Dosimetry-based treatment and radiation exposure monitoring of family caregivers
Sign Up to like & getrecommendations! Published in 2018 at "Physica Medica"
DOI: 10.1016/j.ejmp.2018.04.111
Abstract: Purpose Tandem high-dose based on two administrations of 131I-meta iodobenzylguanidine (131I-mIBG) is the treatment of choice for children with neuroblastoma (NB) with the aim to improve palliation and progression-free survival rates, especially in patients who… read more here.
Keywords: 131i mibg; treatment; family; family caregivers ... See more keywords
Site-based performance of 131I-MIBG imaging and 99mTc-HYNIC-TOC scintigraphy in the detection of nonmetastatic extra-adrenal paraganglioma
Sign Up to like & getrecommendations! Published in 2021 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001490
Abstract: Objectives This study aimed to evaluate the performance of 131I-metaiodobenzylguanidine (MIBG) imaging to detect nonmetastatic extra-adrenal paragangliomas at their respective sites (abdominal vs. thoracic vs. head and neck vs. urinary bladder), and compare it with… read more here.
Keywords: mibg imaging; 131i mibg; 99mtc hynic; hynic toc ... See more keywords
Pediatric 131I-MIBG Therapy for Neuroblastoma: Whole-Body 131I-MIBG Clearance, Radiation Doses to Patients, Family Caregivers, Medical Staff, and Radiation Safety Measures
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000002158
Abstract: Purpose 131I-metaiodobenzylguanidine (131I-MIBG) has been used in the diagnosis and therapy of neuroblastoma in adult and pediatric patients for many years. In this study, we evaluated whole-body 131I-MIBG clearance and radiation doses received by patients,… read more here.
Keywords: therapy; 131i mibg; whole body; radiation ... See more keywords
Feasibility and effectiveness of treatment strategy of tandem high‐dose chemotherapy and autologous stem cell transplantation in combination with 131I‐MIBG therapy for high‐risk neuroblastoma
Sign Up to like & getrecommendations! Published in 2020 at "Pediatric Transplantation"
DOI: 10.1111/petr.13658
Abstract: This study was performed to evaluate the safety and effectiveness of tandem HDCT/ASCT combined with targeted radiotherapy using 131I‐MIBG for high‐risk neuroblastoma. Patients with high‐risk neuroblastoma were treated with 8 to 10 cycles of induction… read more here.
Keywords: 131i mibg; high risk; risk neuroblastoma; hdct asct ... See more keywords
Peripheral Stem Cell Apheresis is Feasible Post 131Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-18-1904
Abstract: Purpose: Targeted radiotherapy with 131iodine-meta-iodobenzylguanidine (131I-MIBG) is effective for neuroblastoma (NBL), although optimal scheduling during high-risk (HR) treatment is being investigated. We aimed to evaluate the feasibility of stem cell apheresis and study hematologic reconstitution… read more here.
Keywords: 131i mibg; apheresis; therapy; stem ... See more keywords
Personalized dosimetry for a deeper understanding of metastatic response to high activity 131I-mIBG therapy in high risk relapsed refractory neuroblastoma.
Sign Up to like & getrecommendations! Published in 2022 at "Quantitative imaging in medicine and surgery"
DOI: 10.21037/qims-21-548
Abstract: Background Dosimetry in molecular radiotherapy for personalized treatment is assuming a central role in clinical management of aggressive/relapsed tumors. Relapsed/refractory metastatic high-risk neuroblastoma (rrmHR-NBL) has a poor prognosis and high-activity 131I-mIBG therapy could represent a… read more here.
Keywords: response; high activity; therapy; 131i mibg ... See more keywords
Low-Dose, Low-Specific Activity 131I-metaiodobenzyl Guanidine Therapy in Metastatic Pheochromocytoma/Sympathetic Paraganglioma: Single-Center Experience from Western India
Sign Up to like & getrecommendations! Published in 2021 at "Indian Journal of Endocrinology and Metabolism"
DOI: 10.4103/ijem.ijem_52_21
Abstract: Introduction: Radionuclide therapy is a promising treatment modality in metastatic pheochromocytoma/paraganglioma (PPGL). There is scarce data on 131I-metaiodobenzyl guanidine (131I-MIBG) therapy from the Indian subcontinent. Hence, we aim to study the safety and effectiveness of… read more here.
Keywords: therapy; 131i mibg; response; mibg therapy ... See more keywords